'Continue laying golden eggs!': Pharma exec, doctors charged by SEC for alleged insider trading around Alexion-Portola deal
After realizing nearly half a million dollars in profits, Stanley Kaplan texted his friend in Russian: “Let’s hope our golden goose will continue laying golden eggs!”
Through a chain of connections, Kaplan had allegedly been tipped confidential information about Alexion’s decision to make a tender offer to buy Portola Pharmaceuticals before the deal was announced in May 2020.
Joseph Dupont, then a vice president at Alexion and part of the biopharma’s acquisitions team, was the originator of the tip, according to Securities and Exchange Commission insider trading charges filed Thursday in the US District Court for the Southern District of New York.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.